Topics:

Cardiovascular Diseases

Cholesterol Management 2013 and Beyond: Two Roads Diverged

The week of November 11, 2013, saw release of the long-awaited update to what had become a stale approach to cholesterol management in the long-term war against cardiovascular disease. Is the document a radical departure from what had gone before? The answer is a resounding “yes.”

Cardiovascular Diseases

Polysomnography or a home-based portable monitor is recommended for clinicians to assess the risk factors for and the symptoms of obstructive sleep apnea.

LDL cholesterol is a common target for treatment, but the guidelines do not used it to estimate risk, either, notes an editorial on the implications of the news guidelines.

discoid lupus erythematosus

Discoid lupus erythematosus; pharmacologic options for “statin-intolerant” patients; treatment of diabetic peripheral neuropathic pain . . . questions on these and other topics in this quiz.

A very large Swedish study and meta-analysis found a dose-response relationship between incident atrial fibrillation and alcohol, with an approximate 8% increase in risk for the arrhythmia per daily drink consumed.

High-sensitivity troponin T and N-terminal-pro-BNP were shown in 2 important studies to help predict risk of stroke and embolic events in patients with atrial fibrillation.

In a proof-of-principle study, German researchers evaluated an affordable, accessible, and cost-effective way to help diagnose atrial fibrillation after ischemic stroke, with promising results.

A painful nodule that keeps this woman up at night; treatment options for nonalcoholic fatty liver disease; risk factors for statin adverse effects . . . some of the topics in this 5-question quiz.

Pages

Subscribe to Cardiovascular Diseases on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.